Modelled DT Structure
Method: homology modeling
Template PDB: 6V4D_A
Identity: 30.085%
Minimized Score: -1015.463 kcal/mol
Detail: Structure Info
Drug Transporter (DT) Information
| General Information of DT | |||||
|---|---|---|---|---|---|
| DT ID | DTD0114 | ||||
| Gene Name | SLC17A1 | ||||
| Protein Name | Sodium-dependent phosphate transport protein 1 | ||||
| Gene ID | |||||
| UniProt ID | |||||
| TCDB ID | |||||
| 3D Structure |
|
||||
| Synonyms | NAPI-1; NPT-1; NPT1; Na(+)/PI cotransporter 1; Na/Pi-4; Renal Na(+)-dependent phosphate cotransporter 1; Renal sodium-dependent phosphate transport protein 1; Renal sodium-phosphate transport protein 1; SLC17A1; Sodium/phosphate cotransporter 1; Solute carrier family 17 member 1 | ||||
| DT Family | Major Facilitator Superfamily (MFS) | ||||
| Anion:Cation Symporter (ACS) Family | |||||
| Tissue Specificity | Expressed in kidney cortex, liver and brainbut not in other tissues. | ||||
| Function | This transporter plays an important role in urate and phosphate transport in the kidney and may be involved in actively transporting phosphate into cells via Na(+) cotransport in the renal brush border membrane. | ||||
| Endogenous Substrate(s) | Na+ | ||||
| Variability Data of This Drug Transporter (DT) | |||||
|
Regulatory Variability Data of This DT (VARIDT 3.0) |
|||||
|
(β) Post-translational Modification of This DT |
|||||
|
(γ) Transcriptional Regulation of This DT |
|||||
|
(δ) Epigenetic Regulation of This DT |
|||||
|
Structural Variability Data of This DT (VARIDT 2.0) |
|||||
|
(β) Inter-species Structural Differences |
|||||
|
General Variability Data of This DT (VARIDT 1.0) |
|||||
|
(α) Genetic Polymorphisms of This DT |
|||||
|
(β) Disease-specific Protein Abundances of This DT |
|||||
|
(γ) Species- and Tissue-specific DT Abundances |
|||||
| Molecular Transporting Profile of This DT | |||||
|
Full List of Drug(s) Transported by This DT |
|||||
|
Approved Drug |
Click to Show/Hide the Full List of Drug: 2 Drugs in Total | ||||
| Drug Name | Highest Status | Detail | Indication | ICD 11 | Ref |
|
Aspirin
|
Approved | Drug Info | Pain | MG30-MG7Z | [1] |
|
Phosphate
|
Approved | Drug Info | Constipation | ME05.0 | [1] |
|
Endogenous Metabolites (EMs) Handled by This DT |
|||||
|
Endogenous Metabolites (EMs) |
Click to Show/Hide the Full List of EMs: 1 EMs in Total | ||||
| EM Name | PubChem CID | Detail | Experimental Material | Ref | |
| Urate | EM Info | Unclear experiment used for identifying this EM | [2] | ||
|
Drug-DT Affinity Assessed by Cell Line |
|||||
|
Approved Drug |
Click to Show/Hide the Full List of Drug: 1 Drugs in Total | ||||
| Drug Name | Highest Status | Detail | Cell Line | Affinity | Ref |
| Aspirin | Approved | Drug Info | Oocytes-NPT1 | Km = 1900 microM | [1] |
| References | |||||
| 1 | Type 1 sodium-dependent phosphate transporter (SLC17A1 Protein) is a Cl(-)-dependent urate exporter. J Biol Chem. 2010 Aug 20;285(34):26107-13. | ||||
| 2 | Recent advances on uric acid transporters. Oncotarget. 2017 Aug 10;8(59):100852-100862. | ||||
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.